Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | 01/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -6.87% | 0.00% | 13.90% | ||
| Total Depreciation and Amortization | -11.03% | 0.00% | 43.26% | ||
| Total Amortization of Deferred Charges | -60.51% | 0.00% | 84.98% | ||
| Total Other Non-Cash Items | -24.12% | 0.00% | -56.41% | ||
| Change in Net Operating Assets | 108.58% | 0.00% | 1,326.09% | ||
| Cash from Operations | -3.50% | 0.00% | 23.86% | ||
| Capital Expenditure | 29.24% | 0.00% | -197.04% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -97.50% | ||
| Cash from Investing | 29.24% | 0.00% | -219.81% | ||
| Total Debt Issued | -- | -- | -100.00% | ||
| Total Debt Repaid | -- | -- | 100.00% | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -100.00% | 0.00% | -50.00% | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -101.94% | 0.00% | 47.22% | ||
| Cash from Financing | -100.21% | 0.00% | -55.60% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -165.72% | 0.00% | -297.07% | ||